Research Article
FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
Table 1
The clinical and pathological characteristics of patients.
| Variable | | Percentage (%) |
| Age (year) | | | <50 | 4 | 2.1 | 50-60 | 23 | 12.2 | 60-70 | 82 | 43.6 | ≥70 | 76 | 40.4 | NA | 3 | 1.6 | Preoperative PSA level (ng/ml) | | | <4 | 2 | 1.1 | 4-10 | 37 | 19.7 | 10-20 | 69 | 36.7 | >20 | 79 | 42.0 | NA | 1 | 0.5 | Gleason score | | | | 9 | 4.8 | | 60 | 31.9 | | 34 | 18.7 | | 79 | 43.4 | NA | 6 | 3.2 | pT category | | | pT2a–2b | 34 | 18.1 | pT2c | 79 | 42.0 | pT3a-b | 71 | 37.8 | pT4 | 4 | 2.1 | pN category | | | pN0 | 121 | 64.4 | pN+ | 32 | 17 | NA | 35 | 18.6 | Surgical margin | | | Negative | 106 | 56.4 | Positive | 82 | 43.6 | Capsular invasion | | | Yes | 68 | 36.2 | No | 120 | 63.8 | Seminal vesicle invasion | | | Yes | 42 | 22.3 | No | 146 | 77.7 | Nerve invasion | | | Yes | 80 | 42.6 | No | 108 | 57.4 |
|
|